Clene to present at Canaccord Growth Conference, host investor meetingsPUBT·1 day ago, 07:32 AMCLNN+5.93%
Clene Inc. (NASDAQ:CLNN) Receives Consensus Rating of "Moderate Buy" from AnalystsMarket Beat·Jul 17 at 05:29 AMCLNN+5.93%STT+1.64%
Top Nanotechnology Stocks Worth Watching - July 11thMarket Beat·Jul 11 at 01:02 PMONTO+13.14%NVEC-1.08%
Clene Extends 2025 Convertible Notes to 2027, Defers $150,000 Monthly PaymentsTradingView·May 22 at 03:43 PMCLNN+5.93%
Clene Extends Debt Maturities and Strengthens Cash RunwayTip Ranks·May 14 at 07:32 AMCLNN+5.93%LABU+3.00%
Clene Extends 2024 Convertible Notes to Aug 13, 2027; Defers $1M Monthly AmortizationTradingView·May 14 at 07:03 AMCLNN+5.93%XLV-1.84%
Clene Reports First Quarter 2026 Financial Results and Recent Operating HighlightsUnusual Whales·May 14 at 07:02 AMCLNN+5.93%
Clene Conference: CEO Says FDA Minutes Suggest CNM-Au8 Data Could Support ALS NDA FilingMarket Beat·May 6 at 04:44 PMCLNN+5.93%
Clene Announces $7 Million Underwritten Offering of Common Stock | CLNN Stock NewsStockTitan·May 4 at 11:45 PMCLNN+5.93%FBT-1.07%
